Dr. Giulio Tarro is Professor in the Department of Oncological Virology at the University of Naples, Italy. He graduated from Medicine School of Naples University (1962). He is a Research Associate at Division of Virology and Cancer Research, Children’s Hospital and Assistant Professor of Research Pediatrics, College of Medicine, Cincinnati University, Ohio. He settled as Division Chief of Virology, and then Department Chief of Diagnostic Laboratories, D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006-. Since 2007 he is Chairman Committee on Biotechnologies and Virus Sphere World Academy Biomedical Technologies, UNESCO, and Adjunct Professor in the Department of Biology at Temple University College of Science and Technology, Philadelphia.
Dr. Giulio Tarro received lifetime achievement award in the year of 2010 from the recipient of the Sbarro Health Research Organization. His Achievements include patents in the field; the discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor-associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas. He has membership in national and international journal’s editorial boards. He also had selected publications over 500 articles in total.
Dr. Giulio Tarro basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation, and characterization of specific virus-induced tumor antigens, which were the “fingerprints”, left behind in human cancer. Achievements include patents in the field; the discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor-associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.
